EXPO EXPONENT
Permanent stock page ↗Consumer Discretionary · Russell 2000
Next earnings: not announced yet
What 6 analyst firms say about EXPONENT: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
5 rated views · 6 analyst/firm records · 6 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)
- Russell 2000 · Safest consensus · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)
Recent analyst activity · last 90 days
Our tracked history has 6 reports on EXPO from 6 analyst firms in the last 90 days (6 firms in the past year).
Comparing each firm's latest target with its previous one: 2 raised their price target and 1 left it unchanged.
Ratings, latest available report against the previous one: 1 upgrade and 0 downgrades.
Latest observed target change: JP Morgan raised its target from $90.00 (set 31 Jul 2026) to $100.00 on 30 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| JPMorgan | Tomohiko Sano | Buy | 30 Oct 2026 | 100.00 USD |
| Truist | Tobey O'Brien Sommer | Buy | 30 Oct 2026 | 90.00 USD |
| UBS | Joshua Chan | Hold | 30 Oct 2026 | 82.00 USD |
| Weiss Ratings | Unnamed analyst | — | 9 Oct 2026 | — |
| William Blair | Andrew O Nicholas | Buy | 30 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Buy | 2 Nov 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 02:45 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.